Synergistic antitumor effects of regulatory T cell blockade combined with pemetrexed in murine malignant mesothelioma. | J Immunol;185(2): 956-66, 2010 Jul 15. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Synergistic antitumor effects of regulatory T cell blockade combined with pemetrexed in murine malignant mesothelioma.

Anraku, Masaki; Tagawa, Tetsuzo; Wu, Licun; Yun, Zhihong; Keshavjee, Shaf; Zhang, Li; Johnston, Michael R; de Perrot, Marc.

Affiliation

Anraku M; Latner Thoracic Surgery Research Laboratories, University Health Network, University of Toronto, Ontario, Canada.

J Immunol ; 185(2): 956-66, 2010 Jul 15.

Article in En | MEDLINE | ID: mdl-20548032

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pleural Neoplasms / Antineoplastic Combined Chemotherapy Protocols / T-Lymphocytes, Regulatory / Mesothelioma / Antibodies, Monoclonal Limits: Animals Language: En Journal: J Immunol Year: 2010 Document type: Article Affiliation country: Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pleural Neoplasms / Antineoplastic Combined Chemotherapy Protocols / T-Lymphocytes, Regulatory / Mesothelioma / Antibodies, Monoclonal Limits: Animals Language: En Journal: J Immunol Year: 2010 Document type: Article Affiliation country: Country of publication: